About Us


Olivier Delporte(*)

Olivier Delporte is an international executive with 20 years of sales, marketing and general management experiences, mostly in the medical devices industry.

Prior to joining Miracor, he was Senior Vice President, Sales & Marketing, US at PneumRx (acquired by BTG in 2015) and, prior to that, the commercial operations of Tryton Medical in Europe, Middle East and Africa, as Vice President of Sales and marketing. Prior to Tryton Medical Management at Guidant and Abbott Vascular. Olivier has studied and worked in the US, France, Spain, and Belgium. He is a director of Endotoxins Therapeutics.

Olivier earned a Masters Degree in Business from the Université Catholique de Louvain, Belgium, and an MBA from the University of Chicago.

(*) represented by ODMC bvba, a management company

Bertrand Grimmonpré(*)

Bertrand Grimmonpré is a seasoned finance executive with 20 years of experience General Management & Finance, with an international exposure for private and quoted groups.

Prior to joining Miracor in January 2017, Bertrand has hold CFO positions in various Medical Devices and Biotech companies like Novoste, Volcano Therapeutics, Celyad (Cardio3) and Medpole.

During the previous years, Bertrand has focused on restructuring, being CEO /CFO for Elo Touch Solutions, Prefarails, 4Decors, Heelys and WOW Technology. He started his career in the Hertz Lease Group, first as Accounting Manager for Ford Cegeac, the largest Ford Dealer in Belgium, then moving to European Finance Controllers, based in Portugal and UK, in charge of integrating newly acquired companies and financial / operational audits.

Bertrand holds a degree in taxation and accounting from the CBC in Brussels, completed with Corporate Finance (ISC St-Louis Brussels) and Interim Management (Vleerick School in Ghent) programs.

(*) represented by B&O Associates SPRL, a management company

Kimberlie O’Connell
Vice President Regulatory, QA & US Operations

Kimberlie has more than 20 years of experience with a focus on cardiovascular therapies. She has held leadership roles in clinical, regulatory and quality for early stage, mid-stage and large organizations.

Prior to joining Miracor, Kim was Vice President of Clinical, Regulatory & Quality for Mitralign, Inc. where she was responsible for all clinical programs, achieving CE Mark and US Early Feasibility approvals for their mitral and tricuspid valve repair therapy.  Kim’s experience also includes 13 years with Medtronic where she held several roles in the Regulatory and Clinical Affairs organizations for the Coronary and Endovascular Therapies businesses.

Kim received a Bachelor of Science degree in Biotechnology from Worcester Polytechnic Institute, a Master’s degree in Regulatory Affairs & Health Policy from Massachusetts College of Pharmacy and MBA from the Van Loan School of Management at Endicott College.

Jozef Tanczos
Vice President Clinical Affairs, Europe

Jozef has more than 15 years of experience in the pharmaceutical and medical device industry in clinical development across all phases for various IMPs, ATMPs and medical devices focus on early and translational medicine in cardiology, pulmonology, organ transplantation and regenerative medicine as well as several years of experience in animal research.

Before joining Miracor, Jozef was Director Medical Affairs and prior to that Director Clinical Affairs at PneumRx BTG where he where he played a key global role supporting clinical development and therapy adoption. Earlier in his career, Jozef worked with Xeltis developing an autologous pulmonary valve and cardiovascular conduits as well as with Roche and Astellas conducting clinical studies on various pharmaceutical products.

Jozef holds a MSc degree in  Biochemistry and Physiology at the Comenius University in Bratislava, Slovak Republic, and work as research fellow at Slovak Academy of Science conducting animal research on  ischemic precondition and myocardial regenerative pathways.

Dr. Ir. Ventzeslav Iordanov
Sr. Director R&D “Console & Software”

Ventzeslav Iordanov has 18 years of experience in the field of system architecture, of which more than 12 years in the medical device products industry. In that time, he led multinational teams in the process of design and development of more that 15 demonstrators and prototypes, and 3 commercial products.

Before joining Miracor, Ventzeslav was Director R&D Medimetrics Personalized Drug Delivery B.V. where he has been responsible for the development and transfers to manufacturing of drug-device combination products. In parallel, he also has led the QA&RA team in defining a Quality Management System (fully compliant to the EU and US regulations) for the support of design, certification and commercialization of medical device products.

Ventzeslav received an Engineer Diploma in Applied Physics from the Sofia University (Bulgaria) a Master’s degree in Electronics from the Sofia University and the Delft University of Technology (The Netherlands) and he holds a PhD in Electronic Instrumentation from the Delft University of Technology.

Steve Cahalane
Sr. Director R&D “Catheter & Detachables” 

Steve Cahalane has over 30 years of experience in the medical device industry.  His experience includes management of Research & Development, Operations and Quality Assurance organizations and ranges from start-up companies to large corporations .

Prior to joining Miracor, Steve was the Chief Technology Officer for Mitralign, Inc. where he was responsible for managing the R&D and Operations departments for their mitral and tricuspid valve repair programs.  Prior to that, Steve worked at Percardia Inc. in product development and Operations management, Boston Scientific in various capacities and the USCI Division of CR Bard as a Quality Engineer.

Steve received a Bachelor of Science degree in Plastics Engineering from the University of Lowell (now the University of Massachusetts Lowell).